1. Home
  2. SLAB vs GRFS Comparison

SLAB vs GRFS Comparison

Compare SLAB & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Silicon Laboratories Inc.

SLAB

Silicon Laboratories Inc.

HOLD

Current Price

$204.82

Market Cap

6.7B

Sector

Technology

ML Signal

HOLD

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$9.01

Market Cap

6.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLAB
GRFS
Founded
1996
1940
Country
United States
Spain
Employees
N/A
23800
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.7B
6.5B
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
SLAB
GRFS
Price
$204.82
$9.01
Analyst Decision
Hold
Hold
Analyst Count
12
2
Target Price
$153.89
$10.15
AVG Volume (30 Days)
1.2M
515.3K
Earning Date
05-06-2026
01-01-0001
Dividend Yield
N/A
1.59%
EPS Growth
66.61
N/A
EPS
N/A
N/A
Revenue
$491,625,000.00
N/A
Revenue This Year
$20.49
$5.47
Revenue Next Year
$16.65
$4.92
P/E Ratio
N/A
$18.67
Revenue Growth
N/A
N/A
52 Week Low
$82.82
$6.19
52 Week High
$208.84
$11.14

Technical Indicators

Market Signals
Indicator
SLAB
GRFS
Relative Strength Index (RSI) 74.15 44.70
Support Level $119.26 $8.66
Resistance Level $208.84 $9.11
Average True Range (ATR) 1.49 0.30
MACD -1.57 -0.05
Stochastic Oscillator 18.75 49.66

Price Performance

Historical Comparison
SLAB
GRFS

About SLAB Silicon Laboratories Inc.

Silicon Laboratories Inc Inc is a provider of secure, intelligent wireless technology for a more connected world. The company's integrated hardware and software platform, intuitive development tools, industry ecosystem, and robust support help customers build industrial, commercial, home, and life applications. Company make it easy for developers to solve complex wireless challenges throughout the product lifecycle and get to market quickly with solutions that transform industries, grow economies, and improve lives. Company operates in USA, China, Taiwan and Rest of World, with maximum revenue from rest of the world.

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Share on Social Networks: